Browsing Tag
S&P Global Ratings
2 posts
Inside Galderma’s €500m bond deal and what it reveals about the dermatology market’s financial momentum
Galderma raises €500M via a five-year eurobond to refinance IPO debt and strengthen its balance sheet. Discover what this means for GALD investors.
Thermo Fisher raises $2.5bn in bonds—But what’s the bigger play behind the debt move?
Thermo Fisher Scientific priced $2.5B in senior notes to fuel acquisitions, refinancing, and growth. See how the deal shapes TMO’s 2026 outlook.